Business Context and Reporting Period
Company: Core Scientific, Inc. (Ticker: CORZ)
Filing Type: Form 8-K (Current Report)
Date of Report: April 22, 2026 (Event Date: May 6, 2026)
Context: The filing announces the completion of a private offering of senior secured notes by a wholly-owned indirect subsidiary, Core Scientific Finance I LLC, and the subsequent repayment of a bridge credit facility.
Key Financial Metrics and Transaction Details
- Debt Issuance: $3.3 billion aggregate principal amount of 7.750% Senior Secured Notes due 2031.
- Issuance Price: 99.250% of principal amount.
- Net Proceeds: Estimated at approximately $3.24 billion after discounts, commissions, and expenses.
- Interest Payments: Semi-annual in arrears, beginning November 15, 2026.
- Amortization: Principal amortizes semi-annually at an initial rate of 11.50% per annum of the outstanding principal.
- Debt Repayment: Full repayment of the $1.0 billion Delayed-Draw Bridge Credit Agreement.
- Collateral: Notes are secured by first-priority liens on substantially all assets of the Issuer and Subsidiary Guarantors, equity interests in Holdco, and Parent Collateral.
Material Changes vs. Prior Period
This filing represents a significant capital structure event rather than a standard periodic financial update. The primary material changes include:
- Debt Profile: Replacement of a $1.0 billion bridge facility with a $3.3 billion long-term senior secured note structure.
- Liquidity: Influx of approximately $3.24 billion in net proceeds, partially allocated to a debt service reserve account and the remainder distributed to Core Scientific for debt repayment.
- Covenants: Implementation of restrictive covenants on the Issuer and Subsidiary Guarantors regarding additional indebtedness, dividends, asset sales, and mergers. Core Scientific (parent) is not subject to these restrictive covenants but provides a completion guarantee.
Guidance, Outlook, and Risks
- Use of Proceeds: Funds are intended to fund a debt service reserve account and repay the Bridge Facility. Remaining proceeds will be distributed to Core Scientific.
- Completion Guarantee: Core Scientific provided an uncapped completion guarantee for specific Projects (excluding the Austin, Texas campus), requiring the parent company to fund completion if note proceeds are insufficient.
- Redemption Terms:
- Pre-May 15, 2028: Redeemable at 100% principal plus accrued interest and a "make-whole" premium. Up to 40% may be redeemed with equity offering proceeds.
- Post-May 15, 2028: Redeemable at specified prices plus accrued interest.
- Change of Control: Mandatory repurchase offer at 101% of principal plus accrued interest.
- Risks: The filing includes standard forward-looking statement disclaimers. Risks include the inability to complete projects, failure to meet covenants, and market conditions affecting the value of the notes or the company's operations.
Investor Verification Checklist
- Verify the specific terms of the "Completion Guarantee" and the definition of "Projects" covered, as this creates a contingent liability for the parent company.
- Review the "Datacenter Lease Termination Event" definition, as this triggers mandatory redemption of notes and affects amortization deferrals.
- Confirm the allocation of the $3.24 billion net proceeds between the debt service reserve and the distribution to Core Scientific.
- Examine the list of Subsidiary Guarantors (Austin, Denton, Dalton, Marble, Muskogee) to understand the scope of assets securing the debt.
- Check for any subsequent filings regarding the actual closing of the $1.0 billion Bridge Facility repayment.